MedTrace Logo

The Programmed Intermittent Epidural Bolus Adrenaline Study

NCT03043781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-09-19

No results posted yet for this study

Summary

This study evaluates the use of intermittent epidural boluses compared to continuous infusion in maintaining epidural pain relief in labor.

The medicine solution used contains, in addition to bupivacain and fentanyl, adrenalin in both groups.

Conditions

  • Labor Pain

Interventions

OTHER

Continuous epidural infusion

Continuous infusion, 5 ml/h

OTHER

Intermittent epidural bolus

Intermittent bolus 5 ml every hour

Sponsors & Collaborators

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Vegard Dahl, MD, Dr. Med. · University Hospital, Akershus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2018-09-05
Completion
2018-09-05

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043781 on ClinicalTrials.gov